glucose, (beta-d)-isomer has been researched along with thalidomide in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyachi, Y; Niwa, Y; Ozaki, M; Uchida, K | 1 |
| Geist, C; Matthiesen, T; Schneider, J; Wöhrmann, T; Zwingenberger, K | 1 |
| Cunha, FQ; Ferreira, SH; Ribeiro, RA; Vale, ML | 1 |
| Benevides, VM; Brito, GA; Cunha, FQ; Ferreira, SH; Poole, S; Ribeiro, RA; Vale, ML | 1 |
| Cui, JR; Li, M; Li, ZJ; Ma, YX; Sun, W; Xu, B; Yang, YP; Yi, WY | 1 |
| Adams, M; Baillie, GS; Bartlett, JB; Capone, L; Cheung, YF; Gandhi, AK; Gilhar, A; Houslay, MD; Loveland, MA; Man, HW; Muller, GW; Parton, A; Schafer, PH; Stirling, DI; Wu, L | 1 |
| Ishida, T | 1 |
| Sigler, J | 1 |
| Hussar, DA | 1 |
9 other study(ies) available for glucose, (beta-d)-isomer and thalidomide
| Article | Year |
|---|---|
Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes.
Topics: Cells, Cultured; Depression, Chemical; Erythema Nodosum; Humans; Hydrogen Peroxide; Hydroxides; Leprosy; Neutrophils; Oxygen; Thalidomide; Zymosan | 1982 |
Local skin reactivity after induction of Shwartzman reaction in rabbits.
Topics: Animals; Dexamethasone; Lipopolysaccharides; Male; Rabbits; Shwartzman Phenomenon; Skin; Thalidomide; Zymosan | 1995 |
Analgesic effect of thalidomide on inflammatory pain.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Blocking; Carrageenan; Edema; Hot Temperature; Hyperalgesia; Male; Mice; Pain; Pain Measurement; Peritoneal Cavity; Physical Stimulation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thalidomide; Tumor Necrosis Factor-alpha; Zymosan | 2000 |
Anti-nociceptive effect of thalidomide on zymosan-induced experimental articular incapacitation.
Topics: Analgesics; Animals; Arthralgia; Arthritis, Experimental; Chemokine CXCL1; Chemokines, CXC; Exudates and Transudates; Immunohistochemistry; Immunosuppressive Agents; Injections, Intraperitoneal; Interleukin-1; Interleukin-6; Knee Joint; Male; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Synovial Membrane; Thalidomide; Tumor Necrosis Factor-alpha; Zymosan | 2006 |
In vitro anticancer property of a novel thalidomide analogue through inhibition of NF-kappaB activation in HL-60 cells.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Genes, Reporter; Glucosides; HL-60 Cells; Humans; Molecular Structure; Neoplasms; NF-kappa B; Poly(ADP-ribose) Polymerases; Thalidomide; Tumor Necrosis Factor-alpha | 2009 |
Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.
Topics: Administration, Oral; Adult; Animals; Anti-Inflammatory Agents; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Enterotoxins; Gene Expression Regulation; Humans; Inflammation Mediators; Keratinocytes; Killer Cells, Natural; Leukocytes, Mononuclear; Lipopolysaccharides; Mice; Mice, SCID; Middle Aged; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Psoriasis; RNA, Messenger; Severity of Illness Index; Skin; Skin Transplantation; Thalidomide; Time Factors; Transplantation, Heterologous; U937 Cells; Ultraviolet Rays; Zymosan | 2010 |
[II. Immunomodulation for multiple myeloma].
Topics: Bone Marrow Transplantation; Glucosides; Humans; Immunomodulation; Lenalidomide; Multiple Myeloma; Phenols; Thalidomide | 2013 |
Drug updates and approvals: 2014 in review.
Topics: Allergens; Benzhydryl Compounds; Benzyl Alcohols; Chlorobenzenes; Drug Approval; Dry Powder Inhalers; Glucagon-Like Peptide 1; Glucosides; Humans; Insulin; Lactones; Nurse Practitioners; Phleum; Plant Extracts; Pollen; Pyrazoles; Pyridines; Pyrimidines; Quinuclidines; Thalidomide; United States; United States Food and Drug Administration | 2014 |
New drugs 2015, part 1.
Topics: Benzhydryl Compounds; Benzyl Alcohols; Chlorobenzenes; Dibenzazepines; Drug Approval; Estrogens, Conjugated (USP); Glucosides; Humans; Indoles; Nitriles; Pyridones; Pyrimidines; Quinuclidines; Thalidomide; United States; United States Food and Drug Administration | 2015 |